200 related articles for article (PubMed ID: 22894964)
1. Modeling the economic value of a Chagas' disease therapeutic vaccine.
Lee BY; Bacon KM; Wateska AR; Bottazzi ME; Dumonteil E; Hotez PJ
Hum Vaccin Immunother; 2012 Sep; 8(9):1293-301. PubMed ID: 22894964
[TBL] [Abstract][Full Text] [Related]
2. The potential economic value of a Trypanosoma cruzi (Chagas disease) vaccine in Latin America.
Lee BY; Bacon KM; Connor DL; Willig AM; Bailey RR
PLoS Negl Trop Dis; 2010 Dec; 4(12):e916. PubMed ID: 21179503
[TBL] [Abstract][Full Text] [Related]
3. The potential economic value of a therapeutic Chagas disease vaccine for pregnant women to prevent congenital transmission.
Bartsch SM; Stokes-Cawley OJ; Buekens P; Asti L; Bottazzi ME; Strych U; Wedlock PT; Mitgang EA; Meymandi S; Falcon-Lezama JA; Hotez PJ; Lee BY
Vaccine; 2020 Apr; 38(16):3261-3270. PubMed ID: 32171575
[TBL] [Abstract][Full Text] [Related]
4. The impact of Chagas disease control in Latin America: a review.
Dias JC; Silveira AC; Schofield CJ
Mem Inst Oswaldo Cruz; 2002 Jul; 97(5):603-12. PubMed ID: 12219120
[TBL] [Abstract][Full Text] [Related]
5. Challenges and opportunities for primary, secondary, and tertiary prevention of Chagas' disease.
Rassi A; Dias JC; Marin-Neto JA; Rassi A
Heart; 2009 Apr; 95(7):524-34. PubMed ID: 19131444
[TBL] [Abstract][Full Text] [Related]
6. Genetic epidemiology of Trypanosoma cruzi infection and Chagas' disease.
Williams-Blangero S; VandeBerg JL; Blangero J; Corrêa-Oliveira R
Front Biosci; 2003 May; 8():e337-45. PubMed ID: 12700060
[TBL] [Abstract][Full Text] [Related]
7. Economic value of a therapeutic Chagas vaccine for indeterminate and Chagasic cardiomyopathy patients.
Bartsch SM; Bottazzi ME; Asti L; Strych U; Meymandi S; Falcón-Lezama JA; Randall S; Hotez PJ; Lee BY
Vaccine; 2019 Jun; 37(28):3704-3714. PubMed ID: 31104883
[TBL] [Abstract][Full Text] [Related]
8. [Pragmatic data and observations related to the epidemiology of Chagas disease].
Schenone H; Rojas A
Bol Chil Parasitol; 1989; 44(3-4):66-86. PubMed ID: 2518649
[TBL] [Abstract][Full Text] [Related]
9. Cruzipain and Its Physiological Inhibitor, Chagasin, as a DNA-Based Therapeutic Vaccine Against
Cerny N; Bivona AE; Sanchez Alberti A; Trinitario SN; Morales C; Cardoso Landaburu A; Cazorla SI; Malchiodi EL
Front Immunol; 2020; 11():565142. PubMed ID: 33162979
[TBL] [Abstract][Full Text] [Related]
10. The economic value of identifying and treating Chagas disease patients earlier and the impact on Trypanosoma cruzi transmission.
Bartsch SM; Avelis CM; Asti L; Hertenstein DL; Ndeffo-Mbah M; Galvani A; Lee BY
PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006809. PubMed ID: 30395603
[TBL] [Abstract][Full Text] [Related]
11. Chagas' disease and blood transfusion: a New World problem?
Wendel S; Gonzaga AL
Vox Sang; 1993; 64(1):1-12. PubMed ID: 8447115
[TBL] [Abstract][Full Text] [Related]
12. The challenge of Chagas' disease: has the human pathogen, Trypanosoma cruzi, learned how to modulate signaling events to subvert host cells?
Lima FM; Oliveira P; Mortara RA; Silveira JF; Bahia D
N Biotechnol; 2010 Dec; 27(6):837-43. PubMed ID: 20172059
[TBL] [Abstract][Full Text] [Related]
13. Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries.
Moncayo A
Mem Inst Oswaldo Cruz; 2003 Jul; 98(5):577-91. PubMed ID: 12973523
[TBL] [Abstract][Full Text] [Related]
14. A cysteine protease inhibitor cures Chagas' disease in an immunodeficient-mouse model of infection.
Doyle PS; Zhou YM; Engel JC; McKerrow JH
Antimicrob Agents Chemother; 2007 Nov; 51(11):3932-9. PubMed ID: 17698625
[TBL] [Abstract][Full Text] [Related]
15. [Chagas' disease in the Amazon: an overview of the current situation and perspectives for prevention].
Dias JC; Prata A; Schofield CJ
Rev Soc Bras Med Trop; 2002; 35(6):669-78. PubMed ID: 12612753
[TBL] [Abstract][Full Text] [Related]
16. Previously unrecognized vaccine candidates control Trypanosoma cruzi infection and immunopathology in mice.
Bhatia V; Garg NJ
Clin Vaccine Immunol; 2008 Aug; 15(8):1158-64. PubMed ID: 18550728
[TBL] [Abstract][Full Text] [Related]
17. Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy.
Moncayo A; Silveira AC
Mem Inst Oswaldo Cruz; 2009 Jul; 104 Suppl 1():17-30. PubMed ID: 19753454
[TBL] [Abstract][Full Text] [Related]
18. Chagas' disease in Latin American immigrants.
Kirchhoff LV; Neva FA
JAMA; 1985 Dec; 254(21):3058-60. PubMed ID: 3932696
[TBL] [Abstract][Full Text] [Related]
19. Chagas' heart disease.
Rassi A; Rassi A; Little WC
Clin Cardiol; 2000 Dec; 23(12):883-9. PubMed ID: 11129673
[TBL] [Abstract][Full Text] [Related]
20. Validation of a rapid immunochromatographic assay for diagnosis of Trypanosoma cruzi infection among Latin-American Migrants in Geneva, Switzerland.
Chappuis F; Mauris A; Holst M; Albajar-Vinas P; Jannin J; Luquetti AO; Jackson Y
J Clin Microbiol; 2010 Aug; 48(8):2948-52. PubMed ID: 20554821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
